Jochen C. Hartner
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Molecular Biology top 2%
- RNA regulation and disease
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- CRISPR and Genetic Engineering
Papers in
-
- MicroRNA in disease regulation 3
-
- RNA regulation and disease 13
- RNA Research and Splicing 8
- RNA and protein synthesis mechanisms 4
- CRISPR and Genetic Engineering 3
- Co-authors
- Peter H. SeeburgMiyoko HiguchiCarl R. WalkleyStuart H. OrkinJun LüFrank N. SingleAndrei RozovDirk Feldmeyer
- Journals
- Brain Research (2 papers)Experimental Hematology (2 papers)Blood (2 papers)Journal of Parkinson s Disease (1 paper)RNA (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Jochen C. Hartner
18 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 741
- Molecular Biology 3.0k
- Immunology 682
- Cardiology and Cardiovascular Medicine 404
- Nephrology 103
Countries citing papers authored by Jochen C. Hartner
This map shows the geographic impact of Jochen C. Hartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen C. Hartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen C. Hartner more than expected).
Fields of papers citing papers by Jochen C. Hartner
This network shows the impact of papers produced by Jochen C. Hartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen C. Hartner. The network helps show where Jochen C. Hartner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen C. Hartner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 11 | |
| 2 | 2018 | 26 | |
| 3 | 2018 | 24 | |
| 4 | 2016 | 54 | |
| 5 | RNA EDITING RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself | 2015 | 3 |
| 6 | RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself Hit paper breakdown → | 2015 | 667 |
| 7 | 2014 | 1 | |
| 8 | 2013 | 1 | |
| 9 | 2013 | 1 | |
| 10 | 2012 | 212 | |
| 11 | MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways Hit paper breakdown → | 2012 | 465 |
| 12 | 2011 | 300 | |
| 13 | 2011 | 10 | |
| 14 | 2008 | 122 | |
| 15 | 2008 | 392 | |
| 16 | 2004 | 406 | |
| 17 | 2003 | 152 | |
| 18 | Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2 Hit paper breakdown → | 2000 | 785 |
About Jochen C. Hartner
Jochen C. Hartner is a scholar working on Cancer Research, Molecular Biology, Immunology, Neurology and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 3.6k indexed citations. Recurring topics across this work include RNA regulation and disease (13 papers), RNA Research and Splicing (8 papers), RNA and protein synthesis mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers), MicroRNA in disease regulation (3 papers), interferon and immune responses (2 papers), Viral Infections and Immunology Research (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Cancer Research (741 citations), Molecular Biology (3.0k citations), Immunology (682 citations), Cardiology and Cardiovascular Medicine (404 citations) and Nephrology (103 citations). Jochen C. Hartner has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Peter H. Seeburg, Miyoko Higuchi, Carl R. Walkley, Stuart H. Orkin, Jun Lü, Frank N. Single, Andrei Rozov, Dirk Feldmeyer, Stefan Maas and Nail Burnashev. Their work appears in journals such as Brain Research, Experimental Hematology, Blood, Journal of Parkinson s Disease and RNA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.